Literature DB >> 26519432

Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model.

Pia Jul, Christiane Volbracht, Inge E M de Jong, Lone Helboe, Anders Brandt Elvang, Jan Torleif Pedersen.   

Abstract

Tauopathies, such as Alzheimer's disease (AD) and frontotemporal dementia (FTD), are characterized by formation of neurofibrillary tangles consisting of hyperphosphorylated tau. In addition to memory loss, patients experience behavioral symptoms such as agitation, aggression, depression, and insomnia. We explored the behavioral phenotype of a mouse model (rTg4510) carrying the human tau P301L mutation found in a familial form of FTD. We tested these mice in locomotor activity assays as well as in the Morris water maze to access spatial memory. In addition to cognitive impairments, rTg4510 mice exhibited a hyperactivity phenotype which correlated with progression of tau pathology and was dependent on P301L tau transgene expression. The hyperactive phenotype was characterized by significantly increased locomotor activity in a novel and in a simulated home cage environment together with a disturbed day/night cycle. The P301L-tau-dependent hyperactivity and agitative-like phenotype suggests that these mice may form a correlate to some of the behavioral disturbances observed in advanced AD and FTD.

Entities:  

Keywords:  Agitation; Alzheimer’s disease; P301L; frontotemporal dementia; hyperactivity; rTg4510

Mesh:

Substances:

Year:  2016        PMID: 26519432     DOI: 10.3233/JAD-150292

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  15 in total

Review 1.  Animal Models of Psychosis in Alzheimer Disease.

Authors:  Josh M Krivinko; Jeremy Koppel; Alena Savonenko; Robert A Sweet
Journal:  Am J Geriatr Psychiatry       Date:  2019-05-17       Impact factor: 4.105

2.  Consequences of Hyperphosphorylated Tau in the Locus Coeruleus on Behavior and Cognition in a Rat Model of Alzheimer's Disease.

Authors:  Michael A Kelberman; Claire R Anderson; Eli Chlan; Jacki M Rorabaugh; Katharine E McCann; David Weinshenker
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.472

3.  Metabolic changes over the course of aging in a mouse model of tau deposition.

Authors:  Aurélie Joly-Amado; Karisa S Serraneau; Milene Brownlow; Caralina Marín de Evsikova; John R Speakman; Marcia N Gordon; Dave Morgan
Journal:  Neurobiol Aging       Date:  2016-04-25       Impact factor: 4.673

4.  Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology.

Authors:  Shalini S Rao; Larissa Lago; Irene Volitakis; Jay J Shukla; Gawain McColl; David I Finkelstein; Paul A Adlard
Journal:  Neurotherapeutics       Date:  2021-01-06       Impact factor: 7.620

5.  Chronic stress induces NPD-like behavior in APPPS1 and WT mice with subtle differences in gene expression.

Authors:  Amalie Clement; Mads M Pedersen; Allan Stensballe; Ove Wiborg; Ayodeji A Asuni
Journal:  Genes Brain Behav       Date:  2021-08-23       Impact factor: 3.708

6.  Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy.

Authors:  Thomas Blackmore; Soraya Meftah; Tracey Karen Murray; Peter James Craig; Anthony Blockeel; Keith Phillips; Brian Eastwood; Michael J O'Neill; Hugh Marston; Zeshan Ahmed; Gary Gilmour; Francois Gastambide
Journal:  Alzheimers Res Ther       Date:  2017-09-20       Impact factor: 6.982

7.  Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy.

Authors:  Xiaohai Wang; Karen Smith; Michelle Pearson; Anna Hughes; Mali L Cosden; Jacob Marcus; J Fred Hess; Mary J Savage; Thomas Rosahl; Sean M Smith; Joel B Schachter; Jason M Uslaner
Journal:  PLoS One       Date:  2018-04-06       Impact factor: 3.240

8.  Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration.

Authors:  C M Holton; N Hanley; E Shanks; P Oxley; A McCarthy; B J Eastwood; T K Murray; A Nickerson; K A Wafford
Journal:  Alzheimers Res Ther       Date:  2020-07-15       Impact factor: 6.982

9.  A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse.

Authors:  Antonio J López-Gambero; Cristina Rosell-Valle; Dina Medina-Vera; Juan Antonio Navarro; Antonio Vargas; Patricia Rivera; Carlos Sanjuan; Fernando Rodríguez de Fonseca; Juan Suárez
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

Review 10.  The physiological roles of tau and Aβ: implications for Alzheimer's disease pathology and therapeutics.

Authors:  Sarah A Kent; Tara L Spires-Jones; Claire S Durrant
Journal:  Acta Neuropathol       Date:  2020-07-29       Impact factor: 15.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.